Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Products
  • Duloxetine Delayed-Release Capsules USP
Where it was sold

US Nationwide.

Nationwide

Units affected
16,473 bottles
About this recall
Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10